Skip to main content

Table 2 Clinical features of individuals with bi-allelic EIF3F variants

From: EIF3F-related neurodevelopmental disorder: refining the phenotypic and expanding the molecular spectrum

Feature

Current study (total no. of indiv. with data; percent of aff. indiv.)

Published study (total no. of indiv. with data; percent of aff. indiv.) [9]

Homozygous for c.694T>G/ p.(Phe232Val)

16 (17; 94%)

9 (9; 100%)

Parental consanguinity

1 (17; 6%)

0 (7; 0%)

Family history

 Affected sibling(s) (bi-allelic EIF3F variants)

4 (17; 24%)

2 (9; 22%)

 Parents with neurological symptoms

2 parents (34; 6%; epilepsy or migraines)

1 parent (14; 7%; mild ID)

Gender

 Female

15 (68%)

5 (56%)

 Male

7 (32%)

4 (44%)

Average age at last examination in years (median)

12.1 ± 9.6 (8.5)

16.3 ± 13.4 (13.0)

Pregnancy/delivery

 Eventful pregnancy

1 (21; 5%; oligo-hydramnios)

1 (9; 11%; abnormal prenatal scan)

 Premature delivery

2 (20; 10%)

0 (9; 0%)

 Perinatal asphyxia

1 (19; 5%; suspected)

0 (9; 0%)

Development

 Global developmental delay

21 (21; 100%)

9 (9, 100%)

 Speech delay

21 (21; 100%)

n.a

 No speech

5 (21; 24%)

n.a

 Regression

3 (21; 14%)

n.a

Behavioral problems

12 (21; 57%)

6 (9; 33%)

Hearing loss

12 (21; 57%)

3 (9; 33%)

Muscular hypo-/hypertonia

10 (21; 48%)

(%)

Ophthalmological findings

 Hyper-/myopia

8 (21; 38%)

 

 Strabismus

3 (21; 14%)

1 (9; 11%)

 Nystagmus

1 (21; 5%)

 

 Coloboma

1 (21; 5%)

 

Brain imaging

 Nonspecific findings

5 (13; 38%)

3 (7; 43%)

Sleeping problems

5 (21; 24%)

n.a

Epilepsy—confirmed

3 (20; 15%)

6 (7; 86%)

Other neurological issues

 Encephalopathy

1 (21; 5%)

n.a

 Meningioma

2 (21; 10%)

 

 Psychosis

1 (21; 5%)

 

Body measurements

 Microcephaly at birth

4 (10; 40%)

0 (1; 0%)

 Short stature at birth

3 (15; 20%)

n.a

 Microcephaly later

6 (19; 32%)

1 (8; 13%)

 Short stature later

8 (20; 40%)

1 (4; 25%)

Malformations

 Cleft lip/ palate (incl. minor form)

2 (20; 10%)

1 (9; 11%)

Gastrointestinal symptoms

5 (21; 24%)

n.a

Dysmorphisms

 Fine facial features

2 (19; 11%)

n.a

 Findings of nose

5 (20; 25%)

 

 Posteriorly rotated ears

7 (20; 35%)

 

 Deep set or encased nails of fingers and/ or toes

6 (20; 30%)

n.a

 Abnormality 5th finger/ toe (shortness, clinodactyly)

3 (20; 15%)

 

 Short hands/ feet or slender fingers/ toes

5 (20; 25%)

 

 Flat feet

3 (20; 15%)

 
  1. Each row indicates the number of individuals/ families with the specified feature (number in parantheses indicate number of individuals with available information on this feature and percentage). Due to an additional confounding diagnosis of MECP2-related disorder in affected individual of P2 and the issue of overlapping phenotypes, we considered this individual only for the first four categories, but no further aspects
  2. aff. indiv.: affected individuals; incl.: including; n.a. not applicable; No./ no.: number